<doc>
  <docmeta id="113s2150is">
    <bill congress="113" type="s" number="2150" version="is"/>
    <revision size="7676" annotations="0" status="complete" id="4" commit-time="2014-04-15T23:04:57Z" committer="mbohmer" doc="113s2150is/4.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-Senate" public-private="public">
  <metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 S2150 IS: Independent Innovator and Repurposing Act</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. Senate</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2014-03-24</dc:date>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">II</distribution-code>
    <congress>113th CONGRESS</congress>
    <session>2d Session</session>
    <legis-num>S. 2150</legis-num>
    <current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
    <action>
      <action-date date="20140324">March 24, 2014</action-date>
      <action-desc>
        <sponsor name-id="S341">Mr. Blumenthal</sponsor> (for himself and <cosponsor name-id="S118">Mr. Hatch</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSJU00">Committee on the Judiciary</committee-name>
      </action-desc>
    </action>
    <legis-type>A BILL</legis-type>
    <official-title>To advance the public health by encouraging independent
		  innovators to pursue drug repurposing research and develop new treatments and
		  cures by providing appropriate intellectual property protections for those
		  innovations, and for other purposes.</official-title>
  </form>
  <legis-body id="H1D86736D491C428485A07A5D9228C2EC" style="OLC">
    <section id="H04071EB7F2AA4D4993298DF81022D7FC" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the
			 <quote>
          <short-title>
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Independent Innovator and Repurposing Act" proposed="true">Independent Innovator and Repurposing
			 Act</cato:entity-ref>
          </short-title>
        </quote>.</text>
    </section>
    <section id="H5844F452DD294C09846D19639F717927">
      <enum>2.</enum>
      <header>Extension of
			 patent term for method of using biological product</header>
      <subsection display-inline="no-display-inline" id="H6D841CD0014644608DC25EE6E361CF28">
        <enum>(a)</enum>
        <header>Extension for
			 regulatory delay</header>
        <text display-inline="yes-display-inline">The term of
			 a patent claiming a method of using a biological product shall be extended
			 for
			 5 years from the original expiration date of the patent, which shall
			 include
			 any patent term adjustment granted under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="uscode" value="usc/35/154/b">
            <external-xref legal-doc="usc" parsable-cite="usc/35/154">section 154(b)</external-xref> of title 35,
			 United
			 States Code</cato:entity-ref>, if—</text>
        <paragraph id="H650E57CC66B74DA78BF4967A43689D69">
          <enum>(1)</enum>
          <text display-inline="yes-display-inline">an application for an extension is
			 submitted by the owner of record of the patent or its agent in accordance
			 with
			 the requirements of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Independent Innovator and Repurposing Act/s:2/ss:b" proposed="true">subsection (b)</cato:entity-ref>; and</text>
        </paragraph>
        <paragraph id="HE49D8B3BBED9471D841C6796F053BDFB">
          <enum>(2)</enum>
          <text>the term of the
			 patent—</text>
          <subparagraph id="H3E7F1BDA59A84BBDACC6092F67381133">
            <enum>(A)</enum>
            <text>has not expired
			 before the application is so submitted; and</text>
          </subparagraph>
          <subparagraph id="H75D38956348845AFAF327E003D8859BA">
            <enum>(B)</enum>
            <text>has not been
			 extended under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Independent Innovator and Repurposing Act/s:2/ss:c" proposed="true">subsection (c) of this section</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="uscode" value="usc/35/156">
                <external-xref legal-doc="usc" parsable-cite="usc/35/156">section 156</external-xref> of title 35,
			 United States Code</cato:entity-ref>.</text>
          </subparagraph>
        </paragraph>
      </subsection>
      <subsection id="HE7B6A13D4FD1433085BE6BBFAC758B14">
        <enum>(b)</enum>
        <header>Application for
			 extension</header>
        <text display-inline="yes-display-inline">To obtain an
			 extension of the term of a patent under this section, the owner of record
			 of
			 the patent or its agent shall submit an application to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1344">Director</cato:entity-ref>. The
			 application shall contain—</text>
        <paragraph id="HF7426B2CFBDA4CE4AB2227463D6DF1F4">
          <enum>(1)</enum>
          <text display-inline="yes-display-inline">the identity of the biological
			 product;</text>
        </paragraph>
        <paragraph id="H467B4A5CF7C2469C8D7A344D84E53F61">
          <enum>(2)</enum>
          <text>the identity of
			 the patent for which an extension is being sought and the identity of each
			 claim of such patent that claims the method of using the biological
			 product;</text>
        </paragraph>
        <paragraph commented="no" id="HF13CA7B19E3C419D957F58A5CB4A8CF7">
          <enum>(3)</enum>
          <text>information
			 demonstrating to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1344">Director</cato:entity-ref> that—</text>
          <subparagraph commented="no" id="H3D84FF3B8B24463CBC5D0EEE85D455D0">
            <enum>(A)</enum>
            <text display-inline="yes-display-inline">the patent was issued to an independent
			 innovator;</text>
          </subparagraph>
          <subparagraph commented="no" id="idC6B551F6BB6843BAA3CFE3490D6CBC07">
            <enum>(B)</enum>
            <text>the owner of record is—</text>
            <clause commented="no" id="id43BD88FD4883465FB427590AE7731E82">
              <enum>(i)</enum>
              <text>the independent innovator; or</text>
            </clause>
            <clause commented="no" id="id4676C18E6FFE4DA99133445D901A1882">
              <enum>(ii)</enum>
              <text>a qualified small business in which the independent innovator has an ownership interest;</text>
            </clause>
          </subparagraph>
          <subparagraph commented="no" id="H1C98A60CBA9F4B0FB7F0CC5B4B6E9D3B">
            <enum>(C)</enum>
            <text>an application
			 under <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                <cato:entity-ref entity-type="act" value="Public Health Service Act/s:351/ss:a">section 351(a) of the Public Health Service Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/262">
                <cato:entity-ref entity-type="uscode" value="usc/42/262/a">42 U.S.C. 262(a)</cato:entity-ref>
              </external-xref>)</cato:entity>
			 for
			 commercial marketing of the biological product for a method of use claimed
			 in
			 the patent has been filed; and</text>
          </subparagraph>
          <subparagraph commented="no" id="H6996D80310AD471BB3CC398FADD6CD16">
            <enum>(D)</enum>
            <text display-inline="yes-display-inline">a period of not less than 10 years elapsed
			 between the original date of submission of an application for an exemption
			 under <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:i">section 505(i) of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/21/355/i">21
			 U.S.C.
			 355(i)</cato:entity-ref>)</cato:entity> for investigating such method of use and the date on which the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7524" entity-type="federal-body">Food and
			 Drug Administration</cato:entity-ref> approved the application described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Independent Innovator and Repurposing Act/s:2/ss:b/p:3/sp:C" proposed="true">subparagraph
			 (C)</cato:entity-ref>;
			 and</text>
          </subparagraph>
        </paragraph>
        <paragraph id="H97D421E4B68C43C581E19EADCCD232E4">
          <enum>(4)</enum>
          <text display-inline="yes-display-inline">a brief description of the activities
			 undertaken by the owner of record of the patent, or the agent of such
			 owner,
			 during such period with respect to the biological product and the
			 significant
			 dates applicable to such activities to the extent such information is
			 possessed
			 by such owner.</text>
        </paragraph>
      </subsection>
      <subsection commented="no" id="HEC2A2EB96FA94A069DE324808B6593BA">
        <enum>(c)</enum>
        <header>Determination of
			 extension</header>
        <paragraph commented="no" id="HADC43C5FD2C54DBEA44B163EECE048C8">
          <enum>(1)</enum>
          <header>In
			 general</header>
          <text display-inline="yes-display-inline">A determination that
			 a patent is eligible for extension shall be made by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1344">Director</cato:entity-ref> solely on
			 the
			 basis of the representations contained in the application for the
			 extension. If
			 the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1344">Director</cato:entity-ref> determines that a patent is eligible for extension under
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Independent Innovator and Repurposing Act/s:2/ss:a" proposed="true">subsection (a)</cato:entity-ref> and that the requirements of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Independent Innovator and Repurposing Act/s:2/ss:b" proposed="true">subsection (b)</cato:entity-ref> have been
			 complied
			 with, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1344">Director</cato:entity-ref> shall issue to the applicant for the extension of the
			 term
			 of the patent a certificate of extension, under seal, for 5 years. Such
			 certificate shall be recorded in the official file of the patent and shall
			 be
			 considered as part of the original patent.</text>
        </paragraph>
        <paragraph commented="no" id="H97CA8B78EC0A44ED9825C5DFCCD370BF">
          <enum>(2)</enum>
          <header>Interim
			 extension</header>
          <text display-inline="yes-display-inline">If the term of a
			 patent for which an application has been submitted under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Independent Innovator and Repurposing Act/s:2/ss:b" proposed="true">subsection (b)</cato:entity-ref>
			 would
			 expire before a certificate of extension is issued or denied under
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Independent Innovator and Repurposing Act/s:2/ss:c/p:1" proposed="true">paragraph
			 (1)</cato:entity-ref> respecting the application, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1344">Director</cato:entity-ref> shall extend, until such
			 determination is made, the term of the patent for periods of up to one
			 year if
			 the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1344">Director</cato:entity-ref> determines that the patent is eligible for extension.</text>
        </paragraph>
      </subsection>
      <subsection id="H548CA7DD366D4980802ACDCCAB0BC8C6">
        <enum>(d)</enum>
        <header>Definitions</header>
        <text>In
			 this section:</text>
        <paragraph id="H7918327B6D614DA8B4595CEFF580CB92">
          <enum>(1)</enum>
          <header>Biological
			 product</header>
          <text>The term <term>biological product</term> has the meaning
			 given to such term in <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Public Health Service Act/s:351/ss:i/p:1">section 351(i)(1) of the Public Health Service Act</cato:entity-ref>
			 (<cato:entity-ref entity-type="uscode" value="usc/42/262/i/1">42
			 U.S.C. 262(i)(1)</cato:entity-ref>)</cato:entity>.</text>
        </paragraph>
        <paragraph id="HDCE9AFE642C44685BE4F4200EE21D281">
          <enum>(2)</enum>
          <header>Director</header>
          <text display-inline="yes-display-inline">The term <term>Director</term> means the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="1344" entity-type="federal-body">Under Secretary of Commerce for Intellectual Property and Director of the
			 United States Patent and Trademark Office</cato:entity-ref>.</text>
        </paragraph>
        <paragraph id="HFC686B6D49A04F7F8FFD89D6BE43C041">
          <enum>(3)</enum>
          <header>Independent
			 innovator</header>
          <subparagraph id="HB2BC22CCE2114347B415A6F769B24360">
            <enum>(A)</enum>
            <text>The term
			 <term>independent innovator</term> means any person or entity that—</text>
            <clause id="H3CE528C5C755428A93B2F6A2D22CE0A4">
              <enum>(i)</enum>
              <text>obtains a method
			 of use patent for a biological product; and</text>
            </clause>
            <clause id="H036ECC27A1C74E6DA529E7E9452C3969">
              <enum>(ii)</enum>
              <text>is
			 not, at the time of invention or patent filing, affiliated with the holder
			 of a
			 marketing application approved under <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                  <cato:entity-ref entity-type="act" value="Public Health Service Act/s:351/ss:a">section 351(a) of the Public Health
			 Service Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/262">
                  <cato:entity-ref entity-type="uscode" value="usc/42/262/a">42 U.S.C. 262(a)</cato:entity-ref>
                </external-xref>)</cato:entity> for the commercial marketing of such
			 biological
			 product.</text>
            </clause>
          </subparagraph>
          <subparagraph id="HDBDE1E0385454E0A86D1FBC9748C7A35">
            <enum>(B)</enum>
            <text>For purposes of
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Independent Innovator and Repurposing Act/s:2/ss:d/p:3/sp:A" proposed="true">subparagraph (A)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Independent Innovator and Repurposing Act/s:2/ss:d/p:4" proposed="true">paragraph (4)</cato:entity-ref>, the term <term>affiliated</term> refers to any relationship
			 of employment, control, or common ownership, whether direct or indirect,
			 including through one or more intermediaries.</text>
          </subparagraph>
        </paragraph>
        <paragraph id="idA188A01022C64CC2A7E60F2801FEBEE6">
          <enum>(4)</enum>
          <header>Qualified small business</header>
          <text>The term <term>qualified
small business</term> means
any entity with fewer
than 500 employees,
including employees
of affiliates, and
which is not affiliated
with the holder of the
marketing application
approved under
<cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Public Health Service Act/s:351/ss:a">section 351(a) of the
Public Health Service
Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/42/sec.">42 U.S.C. sec.
262(a)</cato:entity-ref>)</cato:entity> for the
commercial
marketing of such
biological product.</text>
        </paragraph>
      </subsection>
      <subsection commented="no" id="H60E0C3FC01764CE889C3654933878648">
        <enum>(e)</enum>
        <header>Effective
			 date</header>
        <text display-inline="yes-display-inline">This section shall take
			 effect on the date of the enactment of this Act and shall apply to any
			 unexpired patent issued before, on, or after that effective date.</text>
      </subsection>
    </section>
  </legis-body>
</bill>
</doc>